Associated Papers
CSF3R mutations and variants in myeloid neoplasms: associated phenotypes, co-mutations, and survival trends.
Bolarinwa A et al.
Haematologica, 2025
Chronic Neutrophilic Leukemia: Advances in Diagnosis, Genetic Insights, and Management Strategies.
Elbaz Younes I et al.
Cancers, 2025
CSF3R-mutant chronic myelomonocytic leukemia is a distinct clinically subset with abysmal prognosis: a case report and systematic review of the literature.
Guastafierro V et al.
Leukemia & Lymphoma, 2023
BMX kinase mediates gilteritinib resistance in FLT3-mutated AML through microenvironmental factors.
Buelow DR et al.
Blood Advances, 2022
35797240 (PubMed )
Supplement: advancesADV2022007952-suppl2.xlsx › Suppl_table_7
Distinct genomic landscape of Chinese pediatric acute myeloid leukemia impacts clinical risk classification.
Liu T et al.
Nature Communications, 2022
Co-Occurring CSF3R W791* Germline and Somatic T618I Driver Mutations Induce Early CNL and Clonal Progression to Mixed Phenotype Acute Leukemia.
Adam FC et al.
Current Oncology (toronto, Ont.), 2022
Clonal evolution in a chronic neutrophilic leukemia patient.
Zhang QG et al.
Hematology (amsterdam, Netherlands), 2019
Analysis of gene mutation characteristics in patients with chronic neutrophilic leukaemia.
Yin B et al.
Hematology (amsterdam, Netherlands), 2019
Integrative omics analyses broaden treatment targets in human cancer.
Sengupta S et al.
Genome Medicine, 2018
30053901 (PubMed )
Supplement: 13073_2018_564_MOESM2_ESM.xlsx › 3
Chronic neutrophilic leukemia: new science and new diagnostic criteria.
Szuber N et al.
Blood Cancer Journal, 2018
Characterization of the leukemogenic potential of distal cytoplasmic CSF3R truncation and missense mutations.
Zhang H et al.
Leukemia, 2017
Unpaired Extracellular Cysteine Mutations of CSF3R Mediate Gain or Loss of Function.
Zhang H et al.
Cancer Research, 2017
Enhanced MAPK signaling is essential for CSF3R-induced leukemia.
Rohrabaugh S et al.
Leukemia, 2017
Analysis of acquired mutations in transgenes arising in Ba/F3 transformation assays: findings and recommendations.
Watanabe-Smith K et al.
Oncotarget, 2017
Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML.
Maxson JE et al.
The New England Journal of Medicine, 2013
Select a paper to view details